VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 111 filers reported holding VOYAGER THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $6,516,000 | -34.3% | 1,383,414 | -0.2% | 0.01% | -37.5% |
| Q4 2020 | $9,915,000 | -33.0% | 1,386,665 | +0.0% | 0.01% | -38.5% |
| Q3 2020 | $14,793,000 | -15.0% | 1,386,412 | +0.6% | 0.01% | -18.8% |
| Q2 2020 | $17,394,000 | +57.3% | 1,378,311 | +14.0% | 0.02% | +33.3% |
| Q1 2020 | $11,059,000 | -19.6% | 1,208,675 | +19.4% | 0.01% | +9.1% |
| Q4 2019 | $13,747,000 | -35.5% | 1,012,333 | -18.3% | 0.01% | -42.1% |
| Q3 2019 | $21,323,000 | +106.7% | 1,238,961 | +226.9% | 0.02% | +111.1% |
| Q2 2019 | $10,316,000 | +41.8% | 378,973 | -0.3% | 0.01% | +50.0% |
| Q1 2019 | $7,273,000 | +181725.0% | 379,973 | +93030.6% | 0.01% | – |
| Q4 2018 | $4,000 | -50.0% | 408 | 0.0% | 0.00% | – |
| Q3 2018 | $8,000 | 0.0% | 408 | 0.0% | 0.00% | – |
| Q2 2018 | $8,000 | -99.4% | 408 | -99.4% | 0.00% | -100.0% |
| Q1 2018 | $1,268,000 | +12.2% | 67,500 | -0.8% | 0.00% | 0.0% |
| Q4 2017 | $1,130,000 | +2590.5% | 68,046 | +3214.5% | 0.00% | – |
| Q3 2017 | $42,000 | – | 2,053 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $45,697,000 | 3.92% |
| ARMISTICE CAPITAL, LLC | 3,392,000 | $24,253,000 | 0.82% |
| Bellevue Group AG | 2,712,083 | $19,391,000 | 0.22% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 141,924 | $1,015,000 | 0.17% |
| XTX MARKETS LLC | 10,578 | $76,000 | 0.16% |
| Aevitas Wealth Management, Inc. | 22,150 | $158,000 | 0.12% |
| Virtus ETF Advisers LLC | 35,079 | $251,000 | 0.10% |
| HITE Hedge Asset Management LLC | 29,357 | $210,000 | 0.05% |
| LINCOLN CAPITAL CORP | 10,000 | $72,000 | 0.05% |
| CIM INVESTMENT MANAGEMENT INC | 18,745 | $134,000 | 0.04% |